Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Pharmaceutical industry

Sky-high price of hepatitis C drug produces profits for lawmakers

Editor's pick
Center for Responsive Politics
5 May 2016
Hepatitis C treatment

Antiviral therapies give Hepatitis C cirrhosis patients similar life expectancy as general population

Editor's pick
Eurekalert Medicine & Health
5 May 2016
Hepatitis C treatment

First Canadian Study Demonstrates Potential to Remove Patients from Active Liver Transplant List After Curing Hepatitis C

Editor's pick
Lawson Health Research Institute press release
3 May 2016
Pharmaceutical industry

'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier

Editor's pick
Fierce Pharma
3 May 2016
Hepatitis C treatment

New York Insurers to Change Coverage of Hepatitis C Drugs

Editor's pick
Wall Street Journal
26 April 2016
Hepatitis C treatment

AIDS expert to head $5-million research efforts on hepatitis C

Editor's pick
Vancouver Sun
22 April 2016
Hepatitis C treatment

Hepatitis C: no more treatment rationing; universal access to generic medicines everywhere!

Editor's pick
Treatment Action Group
18 April 2016
Access to healthcare

Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV in Africa and Asia

Editor's pick
World Hepatitis Alliance
14 April 2016
Hepatitis C treatment

Community-based treatment providers can help ease pressure on specialists in battle against hep C

Editor's pick
EASL press release
13 April 2016
Hepatitis C treatment

Differing perspectives on antiviral treatment efficacy in patients co-infected with HIV and HCV

Editor's pick
EASL press release
13 April 2016
Hepatitis C treatment

New report: Hepatitis B and C could be eliminated as public health problems in US

Editor's pick
Eurekalert Inf Dis
12 April 2016
Hepatitis C treatment

No waiting lists for Hepatitis C treatment by August: Egypt's health minister

Editor's pick
Ahram Online
1 April 2016
Hepatitis C treatment

New Travel Horizons: Hepatitis C Tourism From China

Editor's pick
Wall Street Journal (blog)
30 March 2016
Finance & funding

Mortgages For Expensive Health Care? Some Experts Think It Can Work

Editor's pick
Kaiser Health News
29 March 2016
Hepatitis C treatment

Drug subsidies could eliminate Hepatitis C in Australia within a decade, experts say

Editor's pick
ABC Online
29 March 2016
Access to healthcare

Skyhigh drug prices made Romania mull unusual path

Editor's pick
Politico
29 March 2016
Pharmaceutical industry

Merck Wins Chance for Royalties on Gilead’s Hepatitis C Cure

Editor's pick
Bloomberg
24 March 2016
Hepatitis C treatment

Opioid Substitutes Do Not Impede Hep C Combo Drugs

Editor's pick
Medscape
18 March 2016
Hepatitis C treatment

US: VA expands hepatitis C treatment to all patients with the virus

Editor's pick
Military Times
11 March 2016
Pharmaceutical industry

Inside the $100 million ad blitz for a $1100-a-pill drug for hepatitis C

Editor's pick
STAT
9 March 2016
Hepatitis C treatment

Hepatitis medicines: Warning concerning Harvoni® packs with counterfeit contents

Editor's pick
Swiss Agency for Therapeutic Products
8 March 2016
Hepatitis C treatment

20,000 Georgians to Receive Free Hepatitis C Treatment

Editor's pick
Georgia Today
8 March 2016
Pharmaceutical industry

Gilead Spars With Merck Over Hepatitis C $1000-Pill Royalties

Editor's pick
Bloomberg
8 March 2016
Hepatitis C treatment

New York Said to Probe Insurers Over Hepatitis C Drugs

Editor's pick
Bloomberg
4 March 2016